Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
---|
01/09/2007 | CA2261229C Metal ligand containing bleaching compositions |
01/09/2007 | CA2261228C Metal ligand containing bleaching compositions |
01/04/2007 | WO2007002557A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
01/04/2007 | WO2007001406A2 Aryl-containing macrocyclic compounds |
01/04/2007 | CA2611552A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
01/03/2007 | CN1293059C New Carboxglic acid derivative, its preparation and application |
01/02/2007 | US7157464 Substituted piperazines |
01/02/2007 | US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
12/28/2006 | WO2006138510A1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
12/28/2006 | WO2005087752A8 Substituted hydroxyethylamine aspartyl protease inhibitors |
12/28/2006 | US20060292072 Agents for neutron capture therapy |
12/28/2006 | CA2612338A1 Sphingosine kinase inhibitors |
12/27/2006 | EP1736465A1 Aniline derivatives |
12/27/2006 | EP1735293A2 Substituted hydroxyethylamine aspartyl protease inhibitors |
12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
12/27/2006 | EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors |
12/27/2006 | CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring |
12/27/2006 | CN1291980C Method of storing tetrazolium compound, stabilizer for use therein, and tetrazolium compound reagent solution stored by the method |
12/26/2006 | US7153972 Benzimidazole derivatives, their production and use |
12/21/2006 | US20060287537 Method of removing the triphenylmethane protecting group |
12/21/2006 | US20060287360 Novel compounds |
12/21/2006 | US20060287321 Novel Lactam Derivatives |
12/21/2006 | US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
12/20/2006 | EP1732884A1 Sulphonamide derivatives |
12/20/2006 | CN1882347A AKT protein kinase inhibitors |
12/20/2006 | CN1290835C Novel tetrazole derivatives |
12/14/2006 | WO2006132811A2 Ampa receptor potentiators |
12/14/2006 | WO2006131228A1 Method for the production of substituted azoles |
12/14/2006 | WO2006049764A3 Methods of making 2,6-diaryl piperidine derivatives |
12/14/2006 | US20060281801 Process for the preparation of valsartan and its intermediates |
12/14/2006 | CA2611609A1 Ampa receptor potentiators |
12/13/2006 | EP1730125A2 Substituted hydroxyethylamine aspartyl protease inhibitors |
12/13/2006 | CN1878554A 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
12/13/2006 | CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
12/13/2006 | CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
12/13/2006 | CN1289467C Dibenzylamine compound and medicinal use thereof |
12/12/2006 | US7148246 Therapy, prevention diseases of fatty acid metabolism, glucose utilization; insulin resistance; antidiabetic agents; antilipemic agents |
12/12/2006 | US7148219 Biaryl heterocyclic compounds and methods of making and using the same |
12/07/2006 | WO2006130403A1 Phenylalkyl substituted heteroaryl devivatives |
12/07/2006 | US20060276645 Novel carboxylic acid derivatives, their preparation and use |
12/07/2006 | US20060276523 Nitoroxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases |
12/07/2006 | US20060276474 Novel carboxylic acid derivatives, their preparation and use |
12/06/2006 | EP1728784A1 Fluorene derivative |
12/06/2006 | EP1137411B1 Palladium-substituted bacteriochlorophyll derivatives and use thereof |
12/06/2006 | CN1874777A 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
12/06/2006 | CN1287783C Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
12/05/2006 | US7144899 Thrombin inhibitors |
11/29/2006 | EP1726582A2 Compounds and methods for the inhibition of the expression of vcam-1 |
11/29/2006 | EP1725549A1 Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents |
11/29/2006 | CN1287227C Electric photographic organic photoreceptor with charge transfer matter |
11/23/2006 | WO2005112941A3 Substituted cyclic urea derivatives |
11/23/2006 | US20060264426 Antiinfective agent, antiproliferation agent, antiinflammatory agent or prokinetics |
11/22/2006 | EP1724265A1 Anticancer agent |
11/22/2006 | EP1723132A1 Ep2 receptor agonists |
11/22/2006 | EP1723122A2 Dimeric small molecule potentiators of apoptosis |
11/22/2006 | CN1867554A Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors |
11/22/2006 | CN1867551A Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists |
11/22/2006 | CN1867336A 1-aryl-4-substituted piperazines derivatives for use as CCR1 antagonists for the treatment of inflammation and immune disorders |
11/21/2006 | US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives |
11/21/2006 | US7138415 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
11/21/2006 | US7138414 Antidiabetic agents |
11/21/2006 | US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders |
11/21/2006 | CA2272285C Amide derivatives and medicinal compositions thereof |
11/16/2006 | WO2006120444A1 Responsive luminescent lanthanide complexes |
11/16/2006 | CA2598365A1 Analogs of 4-hydroxyisoleucine and uses thereof |
11/15/2006 | CN1863795A P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
11/15/2006 | CN1863765A Process for production of 1-aryl-5-(trifluoromethyl)-1h- tetrazoles |
11/15/2006 | CN1861584A Process of preparing 2,3-disubstituted-tetrazole-5-thione |
11/14/2006 | US7135491 5-Aryltetrazole compounds and uses thereof |
11/14/2006 | US7135487 Sulphonamide derivatives |
11/09/2006 | US20060252673 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
11/08/2006 | EP0993437B1 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as mek inhibitors |
11/08/2006 | CN1283610C Ketone compounds and compositions for cholesterol management and related uses |
11/02/2006 | WO2006115834A1 Angiotensin ii receptor antagonists |
11/02/2006 | WO2006114575A1 Novel development accelerator-releasing couplers |
11/02/2006 | US20060247264 Modulators of the Glucocorticoid Receptor |
11/02/2006 | EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both |
11/02/2006 | EP1716140A1 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives |
11/02/2006 | EP1716125A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits |
11/02/2006 | EP1716116A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents |
11/02/2006 | EP1311493B1 Synthesis of macrocyclic tetraamido ligands useful as bleaching catalysts |
11/02/2006 | CA2604190A1 Angiotensin ii receptor antagonists |
10/31/2006 | US7129361 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments |
10/26/2006 | WO2006113150A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
10/26/2006 | WO2006112723A1 Synthesis of cyclen derivatives |
10/26/2006 | WO2006112685A1 Neurotherapeutic azole compounds |
10/26/2006 | CA2606258A1 Neurotherapeutic azole compounds |
10/26/2006 | CA2604219A1 Synthesis of cyclen derivatives |
10/26/2006 | CA2603757A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
10/25/2006 | EP1714963A1 Process for the Preparation of Valsartan and its Intermediates |
10/25/2006 | CN1852908A Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides |
10/25/2006 | CN1850810A New method for preparing 2-methoxy-5(5-trifluoromethyl-1H-tetraazo-1-group) benzaldehyde |
10/24/2006 | US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
10/24/2006 | US7125910 Compounds and compositions for delivering active agents |
10/24/2006 | US7125871 Excitatory amino acid receptor modulators |
10/24/2006 | US7125869 Drugs for cosmetics for treatment of cardiovadcular disorders, receptors, immunology or lipid metabolism |
10/19/2006 | WO2006029193A3 Process for preparing substituted tetrazoles from aminotetrazole |
10/19/2006 | WO2005087700A3 Bisphenyl compounds useful as vitamin d3 receptor agonists |
10/19/2006 | US20060235057 Phenyl compounds |
10/19/2006 | US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders |